Full Text
Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism

Abstract

Authors

J Ma S Xuan BO Lawson

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×